9-(3,5-diphenylphenyl)-6-(2,3,4,5,6-pentadeuteriophenyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(4-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(5-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline

C124H81N11 — CID 163553902

IUPAC9-(3,5-diphenylphenyl)-6-(2,3,4,5,6-pentadeuteriophenyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(4-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(5-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline
SMILES[2H]c1c([2H])c([2H])c(-n2c3ccc(-c4cc(-c5ccccc5)cc(-c5ccccc5)c4)cc3c3nc4ccccc4nc32)c([2H])c1[2H].c1ccc(-c2cc(-c3ccccc3)cc(-c3ccc4c(c3)c3nc5ccccc5nc3n4-c3cc(-c4ccccc4)ccn3)c2)cc1.c1ccc(-c2ccc(-n3c4ccc(-c5cc(-c6ccccc6)cc(-c6ccccc6)c5)cc4c4nc5ccccc5nc43)nc2)cc1
InChIInChI=1S/2C43H28N4.C38H25N3/c1-4-12-29(13-5-1)33-21-23-41(44-28-33)47-40-22-20-32(27-37(40)42-43(47)46-39-19-11-10-18-38(39)45-42)36-25-34(30-14-6-2-7-15-30)24-35(26-36)31-16-8-3-9-17-31;1-4-12-29(13-5-1)33-22-23-44-41(28-33)47-40-21-20-32(27-37(40)42-43(47)46-39-19-11-10-18-38(39)45-42)36-25-34(30-14-6-2-7-15-30)24-35(26-36)31-16-8-3-9-17-31;1-4-12-26(13-5-1)29-22-30(27-14-6-2-7-15-27)24-31(23-29)28-20-21-36-33(25-28)37-38(41(36)32-16-8-3-9-17-32)40-35-19-11-10-18-34(35)39-37/h2*1-28H;1-25H/i;;3D,8D,9D,16D,17D
InChIKeyFLKAUCQBXWARLH-TZZDCUCNSA-N
MW1730.12 g/mol
LogP31.31
Rot. Bonds14

About 9-(3,5-diphenylphenyl)-6-(2,3,4,5,6-pentadeuteriophenyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(4-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(5-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline

9-(3,5-diphenylphenyl)-6-(2,3,4,5,6-pentadeuteriophenyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(4-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(5-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline (PubChem CID 163553902) has the molecular formula C124H81N11 and a molecular weight of 1730.12 g/mol. Its IUPAC name is 9-(3,5-diphenylphenyl)-6-(2,3,4,5,6-pentadeuteriophenyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(4-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(5-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline.

Molecular Properties

Compound Name9-(3,5-diphenylphenyl)-6-(2,3,4,5,6-pentadeuteriophenyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(4-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(5-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline
PubChem CID163553902
Molecular FormulaC124H81N11
Molecular Weight1730.12 g/mol
Exact Mass1728.70
IUPAC Name9-(3,5-diphenylphenyl)-6-(2,3,4,5,6-pentadeuteriophenyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(4-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(5-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline
SMILES[2H]c1c([2H])c([2H])c(-n2c3ccc(-c4cc(-c5ccccc5)cc(-c5ccccc5)c4)cc3c3nc4ccccc4nc32)c([2H])c1[2H].c1ccc(-c2cc(-c3ccccc3)cc(-c3ccc4c(c3)c3nc5ccccc5nc3n4-c3cc(-c4ccccc4)ccn3)c2)cc1.c1ccc(-c2ccc(-n3c4ccc(-c5cc(-c6ccccc6)cc(-c6ccccc6)c5)cc4c4nc5ccccc5nc43)nc2)cc1
InChIInChI=1S/2C43H28N4.C38H25N3/c1-4-12-29(13-5-1)33-21-23-41(44-28-33)47-40-22-20-32(27-37(40)42-43(47)46-39-19-11-10-18-38(39)45-42)36-25-34(30-14-6-2-7-15-30)24-35(26-36)31-16-8-3-9-17-31;1-4-12-29(13-5-1)33-22-23-44-41(28-33)47-40-21-20-32(27-37(40)42-43(47)46-39-19-11-10-18-38(39)45-42)36-25-34(30-14-6-2-7-15-30)24-35(26-36)31-16-8-3-9-17-31;1-4-12-26(13-5-1)29-22-30(27-14-6-2-7-15-27)24-31(23-29)28-20-21-36-33(25-28)37-38(41(36)32-16-8-3-9-17-32)40-35-19-11-10-18-34(35)39-37/h2*1-28H;1-25H/i;;3D,8D,9D,16D,17D
InChIKeyFLKAUCQBXWARLH-TZZDCUCNSA-N
XLogP31.31
TPSA117.91 Ų
H-Bond Donors
H-Bond Acceptors11
Rotatable Bonds14
Heavy Atoms135
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001730.12
LogP ≤ 531.31
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1011

Analyze 9-(3,5-diphenylphenyl)-6-(2,3,4,5,6-pentadeuteriophenyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(4-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(5-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

9-(3-naphthalen-2-yl-5-phenylphenyl)-6-phenylindolo[3,2-b]quinoxaline
CID 162702048
2-[3-(2,3,4,5,6-pentadeuteriophenyl)-5-(3-phenylphenyl)phenyl]-6-phenylindolo[2,3-b]quinoxaline
CID 162702031
6-(3,5-diphenylphenyl)-9-phenanthren-9-ylindolo[3,2-b]quinoxaline
CID 162702020
1,2,3,4,5,7,8-heptadeuterio-9-phenyl-6-[9-[5-(9-phenylcarbazol-3-yl)-2-pyridinyl]carbazol-3-yl]carbazole;3-[9-[4-[9-(2,3,4,5,6-pentadeuteriophenyl)carbazol-3-yl]phenyl]carbazol-3-yl]-6,9-diphenylcarbazole;5-(2,3,4,5,6-pentadeuteriophenyl)-8-[4-[3-(9-phenylcarbazol-3-yl)carbazol-9-yl]phenyl]pyrido[3,2-b]indole
CID 159673593
9-(9-phenylcarbazol-3-yl)-6-(4-phenylphenyl)indolo[3,2-b]quinoxaline
CID 90336687
6,9-bis(3,5-diphenylphenyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(5-phenylnaphthalen-2-yl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(6-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline
CID 163911559
3-(9-phenylcarbazol-3-yl)-9-(5-phenyl-2-pyridinyl)carbazole
CID 118581881
8-(3,5-diphenylphenyl)-6-(6-phenylnaphthalen-2-yl)indolo[3,2-b]quinoxaline
CID 162701995
9-(3-dibenzothiophen-2-ylphenyl)-6-phenylindolo[3,2-b]quinoxaline;9-(4-dibenzothiophen-2-ylphenyl)-6-phenylindolo[3,2-b]quinoxaline;6-phenyl-9-[3-(9-phenylcarbazol-3-yl)phenyl]indolo[3,2-b]quinoxaline;6-phenyl-9-[3-(5-phenylpyrido[4,3-b]indol-8-yl)phenyl]indolo[3,2-b]quinoxaline
CID 157223495
11-[5-[4,6-bis(2,3,4,5,6-pentadeuteriophenyl)-1,3,5-triazin-2-yl]-2-pyridinyl]-5-phenylindolo[3,2-b]carbazole;11-[4-[4-(2,3,4,5,6-pentadeuteriophenyl)-6-(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-5-phenylindolo[3,2-b]carbazole
CID 158064087
1-(2,3,4,5,6-pentadeuteriophenyl)-2-[10-(3-pyridin-3-ylphenyl)anthracen-9-yl]benzimidazole
CID 169070499
1-(2,3,4,5,6-pentadeuteriophenyl)-2-[3-[3-(2,3,4,5,6-pentadeuteriophenyl)-10-phenylanthracen-9-yl]phenyl]benzimidazole
CID 169070695

Frequently Asked Questions

What is the IUPAC name of 9-(3,5-diphenylphenyl)-6-(2,3,4,5,6-pentadeuteriophenyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(4-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(5-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline?
The IUPAC name of 9-(3,5-diphenylphenyl)-6-(2,3,4,5,6-pentadeuteriophenyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(4-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(5-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline (CID 163553902) is 9-(3,5-diphenylphenyl)-6-(2,3,4,5,6-pentadeuteriophenyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(4-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(5-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline.
What is the SMILES notation for 9-(3,5-diphenylphenyl)-6-(2,3,4,5,6-pentadeuteriophenyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(4-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(5-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline?
The canonical SMILES for 9-(3,5-diphenylphenyl)-6-(2,3,4,5,6-pentadeuteriophenyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(4-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(5-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline is [2H]c1c([2H])c([2H])c(-n2c3ccc(-c4cc(-c5ccccc5)cc(-c5ccccc5)c4)cc3c3nc4ccccc4nc32)c([2H])c1[2H].c1ccc(-c2cc(-c3ccccc3)cc(-c3ccc4c(c3)c3nc5ccccc5nc3n4-c3cc(-c4ccccc4)ccn3)c2)cc1.c1ccc(-c2ccc(-n3c4ccc(-c5cc(-c6ccccc6)cc(-c6ccccc6)c5)cc4c4nc5ccccc5nc43)nc2)cc1.
What is the InChIKey of 9-(3,5-diphenylphenyl)-6-(2,3,4,5,6-pentadeuteriophenyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(4-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(5-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline?
The InChIKey is FLKAUCQBXWARLH-TZZDCUCNSA-N. The full InChI is InChI=1S/2C43H28N4.C38H25N3/c1-4-12-29(13-5-1)33-21-23-41(44-28-33)47-40-22-20-32(27-37(40)42-43(47)46-39-19-11-10-18-38(39)45-42)36-25-34(30-14-6-2-7-15-30)24-35(26-36)31-16-8-3-9-17-31;1-4-12-29(13-5-1)33-22-23-44-41(28-33)47-40-21-20-32(27-37(40)42-43(47)46-39-19-11-10-18-38(39)45-42)36-25-34(30-14-6-2-7-15-30)24-35(26-36)31-16-8-3-9-17-31;1-4-12-26(13-5-1)29-22-30(27-14-6-2-7-15-27)24-31(23-29)28-20-21-36-33(25-28)37-38(41(36)32-16-8-3-9-17-32)40-35-19-11-10-18-34(35)39-37/h2*1-28H;1-25H/i;;3D,8D,9D,16D,17D.
What are the key properties of 9-(3,5-diphenylphenyl)-6-(2,3,4,5,6-pentadeuteriophenyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(4-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(5-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline?
9-(3,5-diphenylphenyl)-6-(2,3,4,5,6-pentadeuteriophenyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(4-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(5-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline has a molecular weight of 1730.12 g/mol, XLogP of 31.31, 14 rotatable bonds, 0 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 9-(3,5-diphenylphenyl)-6-(2,3,4,5,6-pentadeuteriophenyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(4-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline;9-(3,5-diphenylphenyl)-6-(5-phenyl-2-pyridinyl)indolo[3,2-b]quinoxaline is sourced from PubChem (CID 163553902), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).